CDKN2A and neoplasm: Of note, TP53 mut gastric cancer patients with low expression of TP53 mRNA have obvious high expression of TP53, CCNE1 and CDKN2A protein (Figure 3J), which were also confirmed by the immunohistochemistry analysis of tumor specimens from the corresponding clinical cases (Figure 3K).